About Us
															Who We Are
Why Choose Us
- Deep industry knowledge in GxP environments
 - Independent, vendor-neutral advice
 - Proven track record in regulated industries
 - Agile, collaborative approach
 - Results-driven and customer-focused
 
The Team
Andrew Anderson
(CEO)
Andrew Anderson is an accomplished leader with extensive experience in pharmaceutical research and development, specialising in small molecule development and the implementation of novel analytical technologies. Throughout his career at global organisations such as GSK and Johnson & Johnson, he has led strategic initiatives that integrate cutting-edge technologies, including Process Analytical Technology (PAT), automation, novel technologies, and AI into both development and commercial environments.
															Andrew has a proven track record of securing government and academic partnerships, driving innovation through cross-functional leadership, and managing the full lifecycle of technology implementation from scouting to deployment. His work has directly contributed to increased efficiency, enhanced data integrity, and significant resource savings in the development of pharmaceutical products.